WO2007034427A2 - A catheter - Google Patents

A catheter Download PDF

Info

Publication number
WO2007034427A2
WO2007034427A2 PCT/IB2006/053405 IB2006053405W WO2007034427A2 WO 2007034427 A2 WO2007034427 A2 WO 2007034427A2 IB 2006053405 W IB2006053405 W IB 2006053405W WO 2007034427 A2 WO2007034427 A2 WO 2007034427A2
Authority
WO
WIPO (PCT)
Prior art keywords
catheter
balloon
distal end
patients
drainage
Prior art date
Application number
PCT/IB2006/053405
Other languages
French (fr)
Other versions
WO2007034427A3 (en
Inventor
Mehmet Haberal
Fatih Boyvat
Original Assignee
Baskent Universitesi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baskent Universitesi filed Critical Baskent Universitesi
Publication of WO2007034427A2 publication Critical patent/WO2007034427A2/en
Publication of WO2007034427A3 publication Critical patent/WO2007034427A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A61M25/007Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1093Balloon catheters with special features or adapted for special applications having particular tip characteristics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/10Trunk
    • A61M2210/1042Alimentary tract
    • A61M2210/1071Liver; Hepar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/0105Steering means as part of the catheter or advancing means; Markers for positioning
    • A61M25/0108Steering means as part of the catheter or advancing means; Markers for positioning using radio-opaque or ultrasound markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02Holding devices, e.g. on the body
    • A61M25/04Holding devices, e.g. on the body in the body, e.g. expansible
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M27/00Drainage appliance for wounds or the like, i.e. wound drains, implanted drains

Definitions

  • the present invention relates to a catheter used to minimize and check complications in bile ducts after liver transplantation and if necessary, to allow percutaneous intervention.
  • various kinds of catheters are provided to be used for diagnosis, examination, treatment and reducing the amount of fluid in the body by placing it in a gap or space in the body in fields of cardiology, urology, radiology and the like.
  • T-tube catheter which is known in the art, is placed in the choleduct during conventional liver transplantation and it is possible to acquire biliary drainage after the operation and to assess the condition of bile ducts and the relation of choleduct with duodenum or jejunum by inserting contrast material through the tube.
  • Choledochocholedochostomy can be performed by leaving or not leaving internal stent in the bile ducts.
  • bile duct dilatation through percutaneous intervention is difficult and not likely if there is biliary fistula or stricture from anastomosis after the said method.
  • ERCP Endoscopic Retrograde Cholangiopancreatography
  • Another catheter used in the conventional liver transplantation is an angiographic catheter which is commercially available under the trademark of "Soft- Vu” of the firm named “AngioDynamics” and is disclosed in the US Patent No. 5,584,821.
  • the said catheter is a polyether block amid (PEBA) catheter of which the end bears openings for drainage purposes and is covered with tungsten with radiopaque features and which includes internal, middle and external layers (lumen).
  • the internal lumen of the catheter is stated as 0,038 inch, length is 40 cm and size is 5F.
  • the object of the present invention is to provide a catheter which will be used in the liver transplantation and will not leave the place when withdrawn purposely or accidentally.
  • Another object of the invention is to provide a catheter which will reduce the biliary fistulas after the liver transplantation and thus lead to more rapid recovery of the patients.
  • Another object of the invention is to provide a catheter which will check the parts under intervention with the help of its radioopaque distal end during the operation and determine the biliary fistulas.
  • Figure 1 shows a schematic view of one embodiment of the catheter to be used in the adult patients
  • Figure 2 shows a schematic view of one embodiment of the catheter to be used in the child patients.
  • Occurrence rate of bile duct complications after the liver transplantation from live donors varies between 15% and 64%. The rate of complications alters according to the type of anastomosis and use of T-tube or stent. In the early period of liver transplantation hepatico-jejunostomy (HJ) is performed, but today ductus-ductus (DD) anastomosis is much more preferred.
  • HJ hepatico-jejunostomy
  • DD ductus-ductus
  • liver transplantation operations 58 of which were men and 23 were women between April 2001 and May 2005, and average age range 30 ⁇ 19 (minimum 10 months and maximum 65 years). 35 of the total number were pediatric cases, and HJ was applied to 11 pediatric patients and DD anastomosis was applied to the remaining 70 patients. What are the most frequently encountered disorders as transplantation indications were cholestatic and metabolic diseases in pediatric patients and viral hepatitis in adult patients. Transplantation from cadavers were applied to 19 of the said patients and 38 patients are transplanted right lobe of the liver from live donors and 24 are transplanted left lateral segment.
  • the first 61 out of the 81 patients were subjected to conventional methods known in the art, and T-tube or transcystic stent used was placed in the choleduct with incision.
  • the average follow-up period was 16 ⁇ 13 and 8 patients exhibited stenosis and 16 exhibited fistula.
  • the inventive catheter (1) has been developed for minimizing the biliary fistulas and obtaining better results during the application of the new method of the applicant.
  • the said catheter (1) is manufactured from a biocompatible plastic material, polymers, copolymers or other durable materials which can be applied to adult and child patients.
  • the inventive catheter (1) comprises a catheter shaft (4) with 2 cm radiopaque feature and a distal end (2) forming a 20 0 C angle.
  • the catheter (1) for adults comprises a side hole (3) of 5 cm segment (Ll) and for children a side hole (3) of 3 cm (Ll) following the distal end (2) for drainage purposes.
  • the catheter (1) for adults comprises a durable silicone balloon (5) in 25 cm distance
  • Both of the catheters (1) comprise two internal lumens (not shown), one of which allows removing the fluids out of the body and the other inflates the balloon (5).
  • the catheter shaft (4) between the balloon (5) and the distal end (2) of the catheter (1) is 5 French (F) sizes and the catheter shaft (4) between the balloon (5) and the hub (6) is 5 or 6 French (F) sizes.
  • the internal lumen of the catheter is manufactured in an appropriate size for the guide wire of 0,097 cm (0,038 inch) to pass through.
  • An apparatus (not shown) acting as a valve in the inflating of the balloon is placed in the hub (6) of the catheter (1) and prevents draining off the fluids in the balloon (5) when it is inflated.
  • the inventive catheter (1) is manufactured for one-time use and preserved in a sterile package with an expiration date.
  • Biliary fistula was observed in two patients out of 20 patients to whom the inventive catheter (1) of the new technique was applied for decreasing the biliary complication rates. The catheter accidentally came out in the first week and biliary fistula was observed in the patient in the first month. Minor biliary fistula was observed only in one patient and the fistula was fixed in a short time upon opening the catheter for external biliary drainage.

Abstract

The present invention relates to a catheter used to minimize and check complications in bile ducts after liver transplantation and if necessary, to allow percutaneous intervention.

Description

A CATHETER
Technical Field
The present invention relates to a catheter used to minimize and check complications in bile ducts after liver transplantation and if necessary, to allow percutaneous intervention.
Prior Art
In the embodiments known in the prior art, various kinds of catheters are provided to be used for diagnosis, examination, treatment and reducing the amount of fluid in the body by placing it in a gap or space in the body in fields of cardiology, urology, radiology and the like.
Complications of bile ducts after the liver transplantation range between 5,8% and 24,5%. The most important complications are biliary fistulas and anastomotic stricture (Transplantation Proceeding 35, 2316-2317, 2003). Applications like T- tube drainage catheter, transcvtic stent, choledochocholedochostomy (with or without internal stent) and choledochoieiunostomy are well know in the prior art in order to prevent the said complications. (Transplantation 66, 1201-1201, 1988; Transplantation 65, 193-196, 1988).
T-tube catheter, which is known in the art, is placed in the choleduct during conventional liver transplantation and it is possible to acquire biliary drainage after the operation and to assess the condition of bile ducts and the relation of choleduct with duodenum or jejunum by inserting contrast material through the tube. However there are some specific complications of the T-tube. These are:
- Cholangitis,
- Biliary fistula around the T-tube catheter, - Breaking of the T-tube during withdrawal,
- Risk and difficulty of percutaneous intervention to bile ducts from T-tube tract, if there occurs an early complication in the bile ducts, and
- Pains during and after the tube withdrawal. And it is very likely to suffer the same problems during transcystic stent application.
Choledochocholedochostomy can be performed by leaving or not leaving internal stent in the bile ducts. However, bile duct dilatation through percutaneous intervention is difficult and not likely if there is biliary fistula or stricture from anastomosis after the said method.
An intervention with ERCP (Endoscopic Retrograde Cholangiopancreatography) can be performed, but this method causes morbidity and mortality and the possibility to be successful is very low.
Another catheter used in the conventional liver transplantation is an angiographic catheter which is commercially available under the trademark of "Soft- Vu" of the firm named "AngioDynamics" and is disclosed in the US Patent No. 5,584,821. The said catheter is a polyether block amid (PEBA) catheter of which the end bears openings for drainage purposes and is covered with tungsten with radiopaque features and which includes internal, middle and external layers (lumen). The internal lumen of the catheter is stated as 0,038 inch, length is 40 cm and size is 5F.
However, when used in the liver transplantation known in the art the abovementioned catheter causes biliary fistula and may break when removing. When it is necessary to intervene in the bile ducts after the operation it causes intervention difficulties. Consequently, serious problems that lead to late recovery of the patient or death of the patient cannot be avoided. Short Description of the Invention
The object of the present invention is to provide a catheter which will be used in the liver transplantation and will not leave the place when withdrawn purposely or accidentally.
Another object of the invention is to provide a catheter which will reduce the biliary fistulas after the liver transplantation and thus lead to more rapid recovery of the patients.
Another object of the invention is to provide a catheter which will check the parts under intervention with the help of its radioopaque distal end during the operation and determine the biliary fistulas.
Detailed Description of the Invention
The catheter performed to achieve the objects of the invention is illustrated in the accompanying figures in which,
Figure 1 shows a schematic view of one embodiment of the catheter to be used in the adult patients, and
Figure 2 shows a schematic view of one embodiment of the catheter to be used in the child patients.
The parts in the figures are given numerals and the numerals are as follows:
1. Catheter
2. The distal end 3. Hole
4. Shaft 5. Balloon
6. Hub
Occurrence rate of bile duct complications after the liver transplantation from live donors varies between 15% and 64%. The rate of complications alters according to the type of anastomosis and use of T-tube or stent. In the early period of liver transplantation hepatico-jejunostomy (HJ) is performed, but today ductus-ductus (DD) anastomosis is much more preferred.
The applicant carried out a total of 81 liver transplantation operations, 58 of which were men and 23 were women between April 2001 and May 2005, and average age range 30 ± 19 (minimum 10 months and maximum 65 years). 35 of the total number were pediatric cases, and HJ was applied to 11 pediatric patients and DD anastomosis was applied to the remaining 70 patients. What are the most frequently encountered disorders as transplantation indications were cholestatic and metabolic diseases in pediatric patients and viral hepatitis in adult patients. Transplantation from cadavers were applied to 19 of the said patients and 38 patients are transplanted right lobe of the liver from live donors and 24 are transplanted left lateral segment.
The first 61 out of the 81 patients were subjected to conventional methods known in the art, and T-tube or transcystic stent used was placed in the choleduct with incision. The average follow-up period was 16 ± 13 and 8 patients exhibited stenosis and 16 exhibited fistula.
The last 20 patients were subjected to the new method developed by the applicant. In the mentioned technique, after the graft was perfused in the back-table a guide wire was placed through the hepatic channel. After the graft was implanted the guide wire was removed from the abdominal wall and drainage catheter proceeded percutaneously towards the receiver choleduct over the guide wire. The most problematic posterior part of the choledochal anastomosis can be more easily anastomozed by means of drawing the guide wire within the choleduct forward during anastomosis and thus good visualization of posterior wall of choledochal anastomosis.
The inventive catheter (1) has been developed for minimizing the biliary fistulas and obtaining better results during the application of the new method of the applicant.
The said catheter (1) is manufactured from a biocompatible plastic material, polymers, copolymers or other durable materials which can be applied to adult and child patients. The inventive catheter (1) comprises a catheter shaft (4) with 2 cm radiopaque feature and a distal end (2) forming a 200C angle. The catheter (1) for adults comprises a side hole (3) of 5 cm segment (Ll) and for children a side hole (3) of 3 cm (Ll) following the distal end (2) for drainage purposes. The catheter (1) for adults comprises a durable silicone balloon (5) in 25 cm distance
(L2) and for children in 20 cm distance (L2), which can be inflated up to 1 cm.
Both of the catheters (1) comprise two internal lumens (not shown), one of which allows removing the fluids out of the body and the other inflates the balloon (5). There is provided 2 hubs for balloon and the catheter internal lumen after 20 cm distance (L3) in the catheter (1) for adults and after 15 cm distance (L3) in the catheter (1) for children following the balloon (5). The catheter shaft (4) between the balloon (5) and the distal end (2) of the catheter (1) is 5 French (F) sizes and the catheter shaft (4) between the balloon (5) and the hub (6) is 5 or 6 French (F) sizes.
The internal lumen of the catheter is manufactured in an appropriate size for the guide wire of 0,097 cm (0,038 inch) to pass through. An apparatus (not shown) acting as a valve in the inflating of the balloon is placed in the hub (6) of the catheter (1) and prevents draining off the fluids in the balloon (5) when it is inflated. The inventive catheter (1) is manufactured for one-time use and preserved in a sterile package with an expiration date.
Biliary fistula was observed in two patients out of 20 patients to whom the inventive catheter (1) of the new technique was applied for decreasing the biliary complication rates. The catheter accidentally came out in the first week and biliary fistula was observed in the patient in the first month. Minor biliary fistula was observed only in one patient and the fistula was fixed in a short time upon opening the catheter for external biliary drainage.
The complication rates between the patients subjected to HJ and DD anastomosis and patients subjected to the new technique were compared. Two square test of Fisher was used for comparing the complication rates and p< 0,05 was considered significant.
In the prior art, 3 patient with complication were subjected to percutaneous drainage due to bilioma and others percutaneous transhepatic biliary drainage, and it is observed that there is a statistical significant decrease in the complication rates (p=0,03). The biliary stents prevent the development of the biliary complications and facilitate the treatment of the complications since it provides a way for percutaneous intervention. It is thus shown that implanting percutaneous stent is an alternative secure method in liver transplantation for biliary drainage.

Claims

1. A one-time use catheter (1) manufactured from a biocompatible material used in adult and child patients, and implanted percutaneously in the biliary system during liver transplantation, comprising
- a distal end (2) with radioopaque feature,
- side holes (3) for drainage purposes,
- a reinforced catheter shaft (4), and characterized by - a durable silicone balloon (5) inflatable up to 1 cm, following the distal end (2) in a 20 to 25 cm distance (L2),
- 2 hubs (6) for the balloon (5) and the catheter internal lumen (not shown) in a 15 to 20 cm distance (L3) following the balloon (5),
- an apparatus (not shown) placed in the hub (6) acting as a valve in the inflating of the balloon and preventing drainage of the fluids in the balloon (5) when it is inflated.
2. A catheter (1) according to claim 1, characterized in that the catheter (1) comprises a catheter shaft (4) in 5 French (F) sizes between the distal end (2) and balloon (5) and 5 or 6 French (F) sizes between the hub (6) and the balloon (5).
3. A catheter (1) according to any of the foregoing claims, characterized in that the catheter (1) comprises a distal end (2) forming a 200C angle with the catheter shaft (5) and showing a radioopaque feature in 2 cm length.
4. A catheter (1) according to any of the foregoing claims, characterized in that the catheter (1) comprises side holes (3) for drainage purposes in 3 to 5 cm lengths (Ll) following the distal end (2).
5. A catheter (1) according to any of the foregoing claims, characterized in that the catheter (1) comprises an internal lumen in an adequate thickness for the guide wire of 0,097 cm (0,038 inch) to pass through.
PCT/IB2006/053405 2005-09-20 2006-09-20 A catheter WO2007034427A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR200503763 2005-09-20
TR2005/03763 2005-09-20

Publications (2)

Publication Number Publication Date
WO2007034427A2 true WO2007034427A2 (en) 2007-03-29
WO2007034427A3 WO2007034427A3 (en) 2008-10-30

Family

ID=37889227

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/053405 WO2007034427A2 (en) 2005-09-20 2006-09-20 A catheter

Country Status (1)

Country Link
WO (1) WO2007034427A2 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3583404A (en) * 1969-06-23 1971-06-08 Kendall & Co Nonblocking catheter
WO1999058174A2 (en) * 1998-05-08 1999-11-18 Cardeon Corporation Circulatory support system and method of use for isolated segmental perfusion
WO2001024867A1 (en) * 1999-10-06 2001-04-12 Thomas Wolffgram Catheter for carrying out the combined examination of the left ventricle and of the right and left coronary arteries
US20030018309A1 (en) * 2001-07-17 2003-01-23 Breznock Eugene Michael Method and apparatus for chest drainage
US20040193093A1 (en) * 2003-03-25 2004-09-30 Desmond, Joseph P. Retaining stent

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3583404A (en) * 1969-06-23 1971-06-08 Kendall & Co Nonblocking catheter
WO1999058174A2 (en) * 1998-05-08 1999-11-18 Cardeon Corporation Circulatory support system and method of use for isolated segmental perfusion
WO2001024867A1 (en) * 1999-10-06 2001-04-12 Thomas Wolffgram Catheter for carrying out the combined examination of the left ventricle and of the right and left coronary arteries
US20030018309A1 (en) * 2001-07-17 2003-01-23 Breznock Eugene Michael Method and apparatus for chest drainage
US20040193093A1 (en) * 2003-03-25 2004-09-30 Desmond, Joseph P. Retaining stent

Also Published As

Publication number Publication date
WO2007034427A3 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
US20230139854A1 (en) Safe urinary catheter and manufacturing method
US11547836B2 (en) Stabilizing and sealing catheter for use with a guiding catheter
AU606116B2 (en) Perfusion type balloon dilatation catheter and apparatus
Itabashi et al. Self-expanding stainless steel stent application in rectosigmoid stricture
US5163921A (en) Valved perfusion cardiovascular catheters
EP1389073B1 (en) Draining bodily fluids with a stent
US8177741B2 (en) Catheter with superelastic retention device
US8267917B2 (en) Percutaneously retrievable stent assembly with fluid draining capability
JPH042073B2 (en)
WO2001043809A1 (en) Catheter assembly and method for positioning the same at a bifurcated vessel
JP2010503476A (en) A medical catheter with a stress concentrating part in the access port and reduced breaking force
JP2007054646A (en) Endovascular delivery system
JP2010503476A5 (en)
US20060155368A1 (en) Self-expandable stent
US20060264979A1 (en) Novel enhanced vascular surgical device
EP1366731B1 (en) A catheter for treating an intimal dissection
JP2017509364A (en) Balloon catheter
JP4758985B2 (en) Distal wire stop device
CN108578879B (en) Special catheter for children&#39;s reducing saccule dilating vascular stent
US8480652B2 (en) Percutaneous gastrostomy probe with internal collar and biodegradable end piece
WO2007034427A2 (en) A catheter
Beahrs et al. Indwelling ileostomy valve device
US20070167924A1 (en) Pre-curved guiding catheter with eccentric balloon for supplemental backup support
Bjørnstad et al. Balloon debanding of the pulmonary artery
CN113750354B (en) Biliary tract internal drainage device with bracket

Legal Events

Date Code Title Description
NENP Non-entry into the national phase in:

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06821124

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 06821124

Country of ref document: EP

Kind code of ref document: A2